CLINICAL_TRIALS trial_result · 2013-05-07

Clinical Trial Update: An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months [Phase 3]

Open-label Phase 3 safety study evaluating NP101 for acute migraine completed; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: NuPathe Inc. | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2013-05-07